Molecular Biology Market Research Reports & Industry Analysis
In the field of scientific research, molecular biology enzymes, kits, and reagents play a fundamental role in understanding life at the molecular level. As technology and research practices shift, it's essential to stay informed about changes in the molecular biology market. MarketResearch.com offers a selection of authoritative reports to help you navigate this dynamic field.
Gauge the Pulse of the Molecular Biology Market
- In our collection of reports, you will find coverage of a variety of relevant markets including molecular biology simulation software, modeling techniques, laboratory equipment, and more.
- Use our research to gain in-depth analysis of market size, technological advancements, industry trends, and competitor strategies.
- Find objective market data and expert forecasts focusing on major world regions, types, and applications.
Take Advantage of Our Vast Research Database
Whether you are an experienced industry professional, a consultant, or executive, our molecular biology industry reports offer you dependable data to support your decision-making. These reports go beyond the basics — they provide a detailed roadmap to help you outperform competitors, seize emerging opportunities, and excel in an evolving landscape. Browse our collection today to access trusted research at the best price points available.
Molecular Biology Industry Research & Market Reports
-
Single Cell Analysis Market Size, Share & Trends By Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2029
... growth of this market can be attributed to the increasing focus on personalized medicine. The rising R&D investments pharmaceutical & biotechnology industries is propelling the growth of single-cell analysis. Additionally, factors such as growth in ... Read More
-
Europe Liquid Biopsy Market: Focus on End User and Country - Analysis and Forecast, 2024-2033
... 2024-2033. In Europe, liquid biopsy is a new non-invasive diagnostic technique that is transforming cancer detection and surveillance. This method has the potential to early detect cancer recurrence or evaluate treatment responses, and it provides ... Read More
-
Europe Hematologic Malignancies Testing Market: Focus on Product, Platform, Disease, End User, and Country - Analysis and Forecast, 2024-2033
... during the forecast period 2024-2033. Detecting and tracking blood cancers like leukemia, lymphoma, and myeloma is the primary focus of the Europe Hematologic Malignancies Testing Market. The market is expanding significantly due to the increasing ... Read More
-
Global Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
... Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User (Diagnostic Laboratories, Hospitals and Clinics, and Academic and Research Institute), for the historical period of 2020-2023, the estimates of 2024 ... Read More
-
Gel Documentation Systems
... at a CAGR of 4.1% over the analysis period 2024-2030. Gel Documentation Instruments, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$173.1 Million by the end ... Read More
-
Competent Cells
... CAGR of 7.8% over the analysis period 2024-2030. Electrocompetent Cells, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Digital PCRs
... CAGR of 8.0% over the analysis period 2024-2030. Digital PCR Instruments, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$264.8 Million by the end of the ... Read More
-
Arbovirus Testing
... CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis ... Read More
-
Oligonucleotide Synthesis
... CAGR of 15.6% over the analysis period 2024-2030. Oligonucleotide-Based Drugs, one of the segments analyzed in the report, is expected to record a 17.3% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Blotting Systems
... CAGR of 5.4% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$776.2 Million by the end ... Read More
-
Live Cell Imaging
... at a CAGR of 7.5% over the analysis period 2024-2030. Live Cell Imaging Instruments, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.9 Billion by the ... Read More
-
Transfection Technologies
... CAGR of 7.3% over the analysis period 2024-2030. Protein Production Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$694.1 Million by the end of the ... Read More
-
Transfection Reagents and Equipment
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Transfection Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the ... Read More
-
Polymerase Chain Reaction Consumables
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. PCR Tubes, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$250.5 Million by the ... Read More
-
Protein Assays
... CAGR of 6.2% over the analysis period 2024-2030. Protein Assay Kits, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$938.4 Million by the end of the ... Read More
-
In Situ Hybridization (ISH)
... 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.1 ... Read More
-
Molecular Cytogenetics
... CAGR of 8.8% over the analysis period 2024-2030. Molecular Cytogenetics Consumables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.0 Billion by the end of the ... Read More
-
qPCR and dPCR Instrumentation
... 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. qPCR Instrumentation, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$11.3 Billion by the ... Read More
-
High-Resolution Melting Analysis
... at a CAGR of 2.9% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$207.7 Million by the end ... Read More
-
Exosomes
... 11.3% over the analysis period 2024-2030. Other Disease Indications, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$377.0 Million by the end of the analysis period. ... Read More
-
Synthetic Biology
... CAGR of 27.9% over the analysis period 2024-2030. Oligonucleotides & Synthetic DNA Tool, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$39.5 Billion by the end ... Read More
-
Polymerase Chain Reaction
... at a CAGR of 5.0% over the analysis period 2024-2030. PCR Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by the end of ... Read More
-
qPCR Reagents
... CAGR of 7.4% over the analysis period 2024-2030. Dye-Based qPCR Reagents, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
RSV Diagnostics
... CAGR of 7.0% over the analysis period 2024-2030. RSV Diagnostic Kits & Assays, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$686.6 Million by the end ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Pyrogen Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the ... Read More